Combined with its identification as a WGCNA hub gene, a top DEG, and a major feature in diagnostic models, ABCA1 consistently emerges as a key ALS-associated biomarker with mechanistic and therapeutic relevance. The gene discussed is ABCA1; the disease is amyotrophic lateral sclerosis.